5 pending office actions • 3 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Golo LLC | 3 |
| Active Biotech AB | 1 |
| Institute Of Molecular And Cell Biology, Biomedical Sciences Institutes | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18486306 | FORMULATIONS FOR WEIGHT LOSS AND METHODS OF USE | Golo LLC | CONIGLIO, AUDREA JUNE BUCKLEY | 1617 | Non-Final OA | Oct 13, 2023 |
| 18486323 | FORMULATIONS FOR WEIGHT LOSS AND METHODS OF USE | Golo LLC | CONIGLIO, AUDREA JUNE BUCKLEY | 1617 | Non-Final OA | Oct 13, 2023 |
| 18315633 | COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENT | Active Biotech AB | MERTZ, PREMA MARIA | 1674 | Non-Final OA | May 11, 2023 |
| 18305041 | FOOD PRODUCT | Golo LLC | LE, EMILY M | 1793 | Final Rejection | Apr 21, 2023 |
| 17278465 | Cell-based Clostridal Neurotoxin Assays | Institute Of Molecular And Cell Biology, Biomedical Sciences Institutes | BALLARD, KIMBERLY | 1675 | Non-Final OA | Mar 22, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial